Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.300
+0.080 (3.60%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 226 employees as of December 31, 2025. The number of employees increased by 13 or 6.10% compared to the previous year.
Employees
226
Change (1Y)
13
Growth (1Y)
6.10%
Revenue / Employee
$337,969
Profits / Employee
$67,841
Market Cap
185.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| MediWound | 121 |
| Precision BioSciences | 66 |
| Korro Bio | 49 |
| NovaBridge Biosciences | 30 |
| Unicycive Therapeutics | 22 |
| AN2 Therapeutics | 21 |
| Equillium | 15 |
PLX News
- 6 weeks ago - Protalix BioTherapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Protalix BioTherapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Protalix BioTherapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Protalix BioTherapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results - PRNewsWire
- 7 weeks ago - Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026 - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Protalix BioTherapeutics Earnings Call Transcript: Q4 2025 - Transcripts